Results preview: Year 2016

Reig Jofre increased 3% sales and 18% EBITDA between the months of October to December.

Third consecutive quarter of growth, after a first quarter strongly affected by a decrease in the consumption of antibiotics and a weak evolution of the nutritional supplements segment.